-
-
-
-
-
-
-
working groups
-
-
-
-
-
-
-
-
-
Massimo Terzolo, MD
Head of Department of Internal Medicine I
University of Torino
Regione Gonzole 10
Torino, Italy
Period in office: 2019-2025
Dr Judith FAVIER
Research Director, Head of the Genetics and Metabolism of Rare Cancers Laboratory, INSERM U970 – Paris-Cardiovascular Research Centre of the Georges Pompidou Hospital (HEGP), University Paris, Paris, France
Judith Favier was trained as a molecular and cellular biologist as a PhD at the Collège de France (Paris) and a post-doctoral fellow at the Montreal Heart Institute (Canada), during which she studied the role of HIF2a in angiogenesis. Since, her main research interest has been the study of the genetics and the biology of pheochromocytomas and paragangliomas with a particular focus on SDHB-mutated tumors. She holds a Research Director position in the French National Institute of Health and Medical Research (INSERM) and leads the team “Genetics and Metabolism of Rare Cancers” at the PARCC-HEGP. She is the Co-Chairman of the «Animals models» working group of the Pheochromocytoma Research Support Organization (PRESSOR) and was the previous co-chair of PRESSOR (2015-2018). She is an Associate Editor at the Endocrine-related Cancer journal.
Period in office as Head of PPGL WG and treasurer: 2021-2024
Marcus Quinkler, MD
Berlin, Germany
Marcus Quinkler is Professor of Internal Medicine and Endocrinology and consultant in the endocrine outpatient center “Endocrinology in Charlottenburg” in Berlin, Germany.
His clinical research focus includes adrenal physiology and pathophysiology, endocrine hypertension, pituitary disease, and mineralocorticoid and glucocorticoid action.
Professor Quinkler is a member of the Endocrine Society, European Society of Endocrinology and European Network of the study of adrenal tumors. He was speaker of the German Adrenal section of the DGE (German Endocrine Society), and is associated faculty member of the Charité University Medicine Berlin, Germany.period in office: 2021-2024
Marta Araujo-Castro, Madrid, Spain
period in office: 2022-2026
Cristina Ronchi MD, PhD, FRCP, DSc
Institute of Metabolism and Systems Research (IMSR)
University of Birmingham
& Centre for Endocrinology, Diabetes and Metabolism (CEDAM)
Birmingham Health Partners
Birmingham, UK
Dr Cristina L Ronchi is Reader in Endocrine Oncology at the Institute of Metabolism and Systems Research (University of Birmingham, UK). She is also Consultant Endocrinologist at the Queen Elizabeth Hospital Birmingham, where she serves as the Lead of the Adrenal Tumour Specialist Service. Her current research field focuses on the molecular pathogenesis of adrenocortical tumours and Cushing syndrome as well as novel prognostic markers for patients with adrenocortical cancer.
Dr Ronchi is a member of many national and international societies, is on the editorial board of several international journals and coordinated multiple studies on behalf of the ENS@T.
period in office: 2021-2024
period in office: 2024-2027
KIDS Working Group
Christina Pamporaki, MD, PhD, PD habil
Department of Internal Medicine III,
University Hospital Carl Gustav Carus,
Dresden, Germany
Dr. Christina Pamporaki is a consultant endocrinologist and heads the Clinical Research Adrenal Unit at the University Hospital Carl Gustav Carus in Germany. She received her medical degree and completed her PhD Thesis at the University of Ioannina, School of Medicine, in Greece. She has acquired the specialty of “Internal Medicine, Endocrinology and Diabetes” and her Habilitation in “Internal Medicine and Endocrinology” at the Department of Internal Medicine III in the University Hospital Carl Gustav Carus, in Dresden, Germany. Dr. Pamporaki´s research interests focus on adrenal disorders, endocrine hypertension as well as on the application of laboratory analytics in clinical trials.
period in office: 2025-2028
Scientific Advisory Board:
Ruth Casey, Cambridge, UKRonald de Krijger, Utrecht, The Netherlands
Maria Candida Fragoso, São Paulo, Brazil
Enzo Lalli, Valbonne, France
Verena Wiegering, Würzburg, Germany
period in office 2025-2028